Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Le Chesnay-Rocquencourt, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis
FranceStudy Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments
FranceStudy on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis
FranceStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
FranceStudy of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis
FranceStudy on Preventing C. difficile Infections with Oral Vancomycin in Patients Undergoing Allogeneic Stem Cell Transplantation
FranceStudy of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma
FranceStudy on the Effectiveness of Pembrolizumab and Lenvatinib for Patients with Resectable Mucosal Melanoma
FranceStudy on Infertility Risk from Chemotherapy in Young Breast Cancer Patients Using Follitropin Beta and Follitropin Alfa for Egg/Embryo Preservation
FranceLong-term Safety and Efficacy Study of Onasemnogene Abeparvovec in Patients with Spinal Muscular Atrophy
FranceStudy on the Effectiveness and Tolerability of Ofatumumab Compared to a Drug Combination for Patients with Newly Diagnosed Relapsing Multiple Sclerosis
FranceStudy of Entrectinib for Patients with Advanced or Metastatic Solid Tumors with Specific Gene Changes
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myocardial infarction pain management and innovative treatments for severe asthma. Research includes evaluation of novel pain-relief methods and assessment of treatment discontinuation strategies.
Studies also examine beta-blocker discontinuation in patients with recovered heart function.
Extensive research in blood cancers, including multiple myeloma, acute myeloid leukemia, and various lymphomas. Studies evaluate novel drug combinations and treatment strategies.
Investigations include targeted therapies and personalized treatment approaches for various cancer types.
Research focusing on respiratory syncytial virus (RSV) prevention in infants and children. Studies evaluate new protective treatments and their safety profiles.
Trials include assessment of novel medications for preventing severe respiratory infections in vulnerable populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
